Amalgamated Bank Agios Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

$12.2 Billion
Q4 2024

A detailed history of Amalgamated Bank transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,950 shares of AGIO stock, worth $69,166. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,950

Previous 1,950 -0.0%

Holding current value

$69,166

Previous $87,000 26.44%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$27.55 - $48.83 $2,286 - $4,052	83 Added 4.45%	1,950 $84,000
Q1 2024 Apr 23, 2024	SELL	$21.32 - $34.81 $63,363 - $103,455	-2,972 Reduced 61.42%	1,867 $55,000
Q4 2023 Feb 06, 2024	SELL	$19.97 - $24.53 $11,103 - $13,638	-556 Reduced 10.31%	4,839 $108,000
Q2 2023 Aug 11, 2023	SELL	$21.38 - $29.19 $7,996 - $10,917	-374 Reduced 6.48%	5,395 $152,000
Q1 2023 May 02, 2023	SELL	$21.74 - $30.93 $28,066 - $39,930	-1,291 Reduced 18.29%	5,769 $133,000
Q4 2022 Feb 10, 2023	BUY	$24.81 - $31.52 $2,406 - $3,057	97 Added 1.39%	7,060 $198,000
Q3 2022 Nov 09, 2022	BUY	$19.51 - $34.14 $1,326 - $2,321	68 Added 0.99%	6,963 $197,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $5,783 - $10,651	339 Added 5.17%	6,895 $153,000
Q1 2022 Jun 30, 2022	SELL	$26.68 - $34.81 $19,689 - $25,689	-738 Reduced 10.12%	6,556 $191,000
Q4 2021 Feb 15, 2022	SELL	$29.58 - $49.78 $12,541 - $21,106	-424 Reduced 5.49%	7,294 $240,000
Q3 2021 Oct 29, 2021	SELL	$41.92 - $58.18 $39,153 - $54,340	-934 Reduced 10.8%	7,718 $356,000
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $57,630 - $67,825	1,107 Added 14.67%	8,652 $477,000
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $24,680 - $32,085	-558 Reduced 6.89%	7,545 $390,000
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $132 - $186	-4 Reduced 0.05%	8,103 $351,000
Q3 2020 Oct 30, 2020	SELL	$33.87 - $55.93 $440 - $727	-13 Reduced 0.16%	8,107 $284,000
Q2 2020 Aug 10, 2020	SELL	$34.45 - $53.48 $177,314 - $275,261	-5,147 Reduced 38.8%	8,120 $434,000
Q1 2020 May 13, 2020	SELL	$31.52 - $53.81 $5,642 - $9,631	-179 Reduced 1.33%	13,267 $471,000
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $86,058 - $144,737	2,861 Added 27.03%	13,446 $642,000
Q3 2019 Nov 13, 2019	BUY	$32.4 - $49.58 $3,661 - $5,602	113 Added 1.08%	10,585 $343,000
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $43,492 - $64,150	-942 Reduced 8.25%	10,472 $522,000
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $8,495 - $12,518	185 Added 1.65%	11,414 $770,000
Q4 2018 Feb 15, 2019	BUY	$42.73 - $76.53 $175,705 - $314,691	4,112 Added 57.78%	11,229 $518,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $326,098 - $418,372	-4,550 Reduced 39.0%	7,117 $549,000
Q2 2018 Jul 18, 2018	BUY	$73.22 - $99.55 $87,424 - $118,862	1,194 Added 11.4%	11,667 $983,000
Q1 2018 May 22, 2018	BUY	$59.83 - $86.53 $130,788 - $189,154	2,186 Added 26.38%	10,473 $856,000
Q4 2017 Feb 13, 2018	BUY	$52.12 - $72.33 $23,975 - $33,271	460 Added 5.88%	8,287 $474,000
Q3 2017 Nov 09, 2017	BUY	$54.89 - $67.12 $429,624 - $525,348	7,827	7,827 $522,000

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.94B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Agios Pharmaceuticals, Inc. Transaction History